The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease
Open accessAbstract
Gastroesophageal junction carcinoma is a rare but often lethal condition with increasing importance as a public health problem in recent decades. While diagnosis of this disease has been complicated historically by the lack of uniform classification standards, available data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry program in the United States show an approximate 2.5-fold increase in the incidence of gastroesophageal junction adenocarcinoma (GEJAC) from 1973–1992, with rates stabilizing in the last two decades. Similar proportional trends are observed among subgroups defined by race and gender, but rates are significantly higher in males relative to females, and in white males relative to black males. Smoking, obesity, and gastroesophageal reflux disease are significant risk factors for GEJAC, and may account for a substantial fraction of total disease burden. Infection with Helicobacter pylori has been associated with reduced incidence, and high dietary fiber intake has also been linked to lower disease risk. Ongoing studies continue to explore a potential role for non-steroidal anti-inflammatory drugs in chemoprevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Classification of adenocarcinoma of the oesophagogastric junction
Siewert, J. R., & Stein, H. J. (1998) · Journal of British Surgery · doi:10.1046/j.1365-2168.1998.00940.x · Cited by 1,267
Population Attributable Risks of Esophageal and Gastric Cancers
Engel, L. S., Chow, W.-H., Vaughan, T. L., Gammon, M. D., Risch, H. A., Stanford, J. L., Schoenberg, J. B., Mayne, S. T., Dubrow, R., Rotterdam, H., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg047 · Cited by 775
Self-citationAssociation between Body Mass and Adenocarcinoma of the Esophagus and Gastric Cardia
Lagergren, J., Bergström, R., & Nyrén, O. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00003 · Cited by 675
Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
Chow, W.-H., Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D., Stanford, J. L., Dubrow, R., Schoenberg, J. B., Mayne, S. T., Farrow, D. C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.150 · Cited by 626
Self-citationHelicobacter infection and gastric neoplasia
Peek, R. M., & Crabtree, J. E. (2006) · The Journal of Pathology · doi:10.1002/path.1868 · Cited by 550
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
Botterweck, A. A., Schouten, L. J., Volovics, A., Dorant, E., & van den Brandt, P. A. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.4.645 · Cited by 537
Chow, W.-H., Blaser, M. J., Blot, W. J., et al. (1998) · PubMed · Cited by 529
Epidemiology and Pathogenesis of Esophageal Cancer
Holmes, R. S., & Vaughan, T. L. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.09.003 · Cited by 527
Self-citationYang, L., Lu, X., Nossa, C. W., Francois, F., Peek, R. M., & Pei, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.046 · Cited by 490
Nutrient intake and risk of subtypes of esophageal and gastric cancer.
Mayne, S. T., Risch, H. A., Dubrow, R., Chow, W. H., Gammon, M. D., Vaughan, T. L., Farrow, D. C., Schoenberg, J. B., Stanford, J. L., Ahsan, H., et al. (2001) · PubMed · Cited by 433
Self-citationKubo, A., & Corley, D. A. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0860 · Cited by 416
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
Reid, B. J., Li, X., Galipeau, P. C., & Vaughan, T. L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2773 · Cited by 378
Self-citationChow, W.-H. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530060048032 · Cited by 365
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<340::aid-ijc8>3.0.co;2-n · Cited by 337
Kamangar, F., Dawsey, S. M., Blaser, M. J., Perez-Perez, G. I., Pietinen, P., Newschaffer, C. J., Abnet, C. C., Albanes, D., Virtamo, J., & Taylor, P. R. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj393 · Cited by 330
Cook, M. B., Kamangar, F., Whiteman, D. C., Freedman, N. D., Gammon, M. D., Bernstein, L., Brown, L. M., Risch, H. A., Ye, W., Sharp, L., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq289 · Cited by 316
Self-citationWhiteman, D. C., Sadeghi, S., Pandeya, N., Smithers, B. M., Gotley, D. C., Bain, C. J., Webb, P. M., Green, A. C., & Study, F. T. A. C. (2008) · Gut · doi:10.1136/gut.2007.131375 · Cited by 307
Hoyo, C., Cook, M. B., Kamangar, F., Freedman, N. D., Whiteman, D. C., Bernstein, L., Brown, L. M., Risch, H. A., Ye, W., Sharp, L., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys176 · Cited by 300
Self-citationEpidemiology of esophageal adenocarcinoma
Pera, M., Manterola, C., Vidal, O., & Grande, L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20357 · Cited by 298
Wu, A. H., Wan, P., & Bernstein, L. (2001) · Cancer Causes & Control · doi:10.1023/a:1011290704728 · Cited by 297
Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia
Kabat, G. C., Ng, S. K. C., & Wynder, E. L. (1993) · Cancer Causes and Control · doi:10.1007/bf00053153 · Cited by 281
Green, J., Czanner, G., Reeves, G., Watson, J., Wise, L., & Beral, V. (2010) · BMJ · doi:10.1136/bmj.c4444 · Cited by 275
Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
Cardwell, C. R., Abnet, C. C., Cantwell, M. M., & Murray, L. J. (2010) · JAMA · doi:10.1001/jama.2010.1098 · Cited by 224
Ekstrom, A. M., Signorello, L. B., Hansson, L.-E., Bergstrom, R., Lindgren, A., & Nyren, O. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.786 · Cited by 221
Vaughan, T. L., Dong, L. M., Blount, P. L., Ayub, K., Odze, R. D., Sanchez, C. A., Rabinovitch, P. S., & Reid, B. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70431-9 · Cited by 218
Self-citationAdenocarcinomas of the esophagus and gastric cardia: The role of diet
Zhang, Z., Kurtz, R. C., Yu, G., Sun, M., Gargon, N., Karpeh, M., Fein, J. S., & Harlap, S. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514541 · Cited by 216
Abdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas
Corley, D. A., Kubo, A., & Zhao, W. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0748 · Cited by 211
Abnet, C. C., Freedman, N. D., Kamangar, F., Leitzmann, M. F., Hollenbeck, A. R., & Schatzkin, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604880 · Cited by 181
Liao, L. M., Vaughan, T. L., Corley, D. A., Cook, M. B., Casson, A. G., Kamangar, F., Abnet, C. C., Risch, H. A., Giffen, C., Freedman, N. D., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.019 · Cited by 162
Self-citationO'Doherty, M. G., Freedman, N. D., Hollenbeck, A. R., Schatzkin, A., & Abnet, C. C. (2012) · Gut · doi:10.1136/gutjnl-2011-300551 · Cited by 158
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985
Hansson, L.-E., Sparén, P., & Nyrén, O. (1993) · British journal of surgery · doi:10.1002/bjs.1800800338 · Cited by 139
Whiteman, D. C., Parmar, P. G. K., Fahey, P. P., Moore, S., Stark, M. S., Zhao, Z., Montgomery, G. W., Green, A. C., Hayward, N. K., & Webb, P. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.009 · Cited by 125
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium
Freedman, N. D., Murray, L. J., Kamangar, F., Abnet, C. C., Cook, M. B., Nyrén, O., Ye, W., Wu, A. H., Bernstein, L., Brown, L. M., et al. (2011) · Gut · doi:10.1136/gut.2010.233866 · Cited by 116
Self-citationTobacco Smoking and Esophageal and Gastric Cardia Adenocarcinoma
Tramacere, I., Vecchia, C. L., & Negri, E. (2011) · Epidemiology · doi:10.1097/ede.0b013e31821092cd · Cited by 111
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk
Tramacere, I., Pelucchi, C., Bagnardi, V., Rota, M., Scotti, L., Islami, F., Corrao, G., Boffetta, P., Vecchia, C. L., & Negri, E. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr136 · Cited by 111
Das, D., Ishaq, S., Harrison, R. F., Kosuri, K., Harper, E., Caestecker, J. S. D., Sampliner, R. E., Attwood, S., Barr, H., Watson, P. J., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01790.x · Cited by 102
Bahmanyar, S., & Ye, W. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5402_3 · Cited by 96
Aspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus
Sadeghi, S., Bain, C. J., Pandeya, N., Webb, P. M., Green, A. C., Whiteman, D. C., & Study, F. T. A. C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2852 · Cited by 81
Dating the Rise of Esophageal Adenocarcinoma: Analysis of Connecticut Tumor Registry Data, 1940–2007
Abrams, J. A., Sharaiha, R. Z., Gonsalves, L., Lightdale, C. J., & Neugut, A. I. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0802 · Cited by 77
Pathology of the gastroesophageal junction
Odze, R. D. (2005) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2006.04.007 · Cited by 73
Population Attributable Fractions of Adenocarcinoma of the Esophagus and Gastroesophageal Junction
Olsen, C. M., Pandeya, N., Green, A. C., Webb, P. M., Whiteman, D. C., & Study, F. T. A. C. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr117 · Cited by 73
Pandeya, N., Webb, P. M., Sadeghi, S., Green, A. C., & Whiteman, D. C. (2009) · Gut · doi:10.1136/gut.2009.190827 · Cited by 64
Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry
Wayman, J., Forman, D., & Griffin, S. M. (2001) · Cancer Causes & Control · doi:10.1023/a:1013756531219 · Cited by 61
Parfitt, J. R., Miladinovic, Z., & Driman, D. K. (2006) · Canadian Journal of Gastroenterology · doi:10.1155/2006/175751 · Cited by 54
Subsite-Specific Risk Factors for Esophageal and Gastric Adenocarcinoma
Crane, S. J., Locke, G. R., Harmsen, W. S., Diehl, N. N., Zinsmeister, A. R., Melton, L. J., Romero, Y., & Talley, N. J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01234.x · Cited by 44
Levi, F., Te, V.-C., Randimbison, L., & Vecchia, C. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1585a · Cited by 29
An Evaluation of the Use of Oral Bisphosphonates and Risk of Esophageal Cancer
Haber, S. L., & McNatty, D. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q482 · Cited by 18
Cited by
The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer
Moss, S. F. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.12.001 · Cited by 321
Van Cutsem, E., di Bartolomeo, M., Smyth, E., Chau, I., Park, H., Siena, S., Lonardi, S., Wainberg, Z. A., Ajani, J., Chao, J., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00215-2 · Cited by 265
Metadata
- Authors
- Buas, M. F., & Vaughan, T. L.
- Venue
- Seminars in Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 23
- Issue
- 1
- Pages
- 3-9
- ISSN
- 1053-4296 (ISSN-L)
- OpenAlex
- W2074134583
- Cited by
- 316
- References
- 49
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.